Cresp (Darbepoetin alfa) Injection is a prescription drug used to treat anemia due to chronic kidney disease or due to chemotherapy. Cresp 40mcg injection is an erythropoiesis-stimulating agent (ESA). It Stimulates bone marrow to produce more red blood cells.
Manufacturer : Dr Reddy’s Laboratories Ltd.
Strengths available : 25mcg, 40mcg, 60mcg, 100mcg & 200mcg
Storage : Store at temperature between 2°C – 8°C
Renal Anemia: Hemodialysis Patients:
The usual dose of Cresp in adult patients is 20 μg as Cresp (genetical recombination), to be administered as a single intravenous injection once weekly.
Peritoneal Dialysis Patients And Patients With Chronic Kidney Disease Not On Dialysis:
The usual dose of Cresp in adult patients is 30 μg as Cresp (genetical recombination), to be administered as a single injection once every two weeks subcutaneously or intravenously.
Treatment of Anemia in Cancer Patients Receiving Myelosuppressive Chemotherapy:
Initiate Cresp in patients on cancer chemotherapy only if the hemoglobin is less than 10 g/dL, and if there is a minimum of two additional months of planned chemotherapy.
Common side effects are Increased blood pressure, Hypersensitivity.